Vireo Growth (VREOF) Retained Earnings (2020 - 2026)
Vireo Growth's (VREOF) quarterly Retained Earnings came in at -$319.9 million in Q1 2026, down 34.44% year-on-year from -$488.0 million in Q1 2025, and down 6.78% quarter-over-quarter from -$299.6 million in Q4 2025.
Vireo Growth (VREOF) Retained Earnings (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Retained Earnings across 7 years of filings, most recently posting -$319.9 million for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$319.9 million, down 34.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$319.9 million (down 34.44% YoY), and the FY2025 annual result was -$299.6 million, down 29.45% from the prior year.
- Retained Earnings came in at -$319.9 million for Q1 2026 at Vireo Growth, down from -$299.6 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$150.0 million in Q1 2022 to a low of -$319.9 million in Q1 2026.
- The 5-year median for Retained Earnings is -$210.1 million (2024), against an average of -$217.0 million.
- Across the five-year window, Retained Earnings slumped 37.96% in 2022 and decreased 8.49% in 2024, its largest moves.
- Vireo Growth's Retained Earnings stood at -$177.9 million in 2022, then fell by 14.36% to -$203.4 million in 2023, then retreated by 13.77% to -$231.4 million in 2024, then fell by 29.45% to -$299.6 million in 2025, then fell by 6.78% to -$319.9 million in 2026.
- The last three Retained Earnings figures came in at -$319.9 million (Q1 2026), -$299.6 million (Q4 2025), and -$279.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn | -319.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -319.90 Mn |
| Dec 31, 2025 | -299.60 Mn |
| Sep 30, 2025 | -279.18 Mn |
| Jun 30, 2025 | -252.88 Mn |
| Mar 31, 2025 | -237.94 Mn |
| Dec 31, 2024 | -231.44 Mn |
| Sep 30, 2024 | -215.73 Mn |
| Jun 30, 2024 | -210.81 Mn |
| Mar 31, 2024 | -210.14 Mn |
| Dec 31, 2023 | -203.43 Mn |
| Sep 30, 2023 | -198.85 Mn |
| Jun 30, 2023 | -193.62 Mn |
| Mar 31, 2023 | -186.29 Mn |
| Dec 31, 2022 | -177.88 Mn |
| Sep 30, 2022 | -164.60 Mn |
| Jun 30, 2022 | -156.17 Mn |
| Mar 31, 2022 | -149.99 Mn |
| Dec 31, 2021 | -135.42 Mn |
| Sep 30, 2021 | -120.44 Mn |
| Jun 30, 2021 | -114.20 Mn |